Literature DB >> 34911937

Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination.

Ved P Sharma1,2, Binwu Tang3, Yarong Wang1,2,4, Camille L Duran1, George S Karagiannis1,4, Emily A Xue1, David Entenberg1,2,4, Lucia Borriello1, Anouchka Coste1,5, Robert J Eddy1, Gina Kim1, Xianjun Ye1, Joan G Jones1,4,6,7, Eli Grunblatt8, Nathan Agi8, Sweta Roy8, Gargi Bandyopadhyaya8, Esther Adler9, Chinmay R Surve1,4, Dominic Esposito10, Sumanta Goswami1,8, Jeffrey E Segall1,2, Wenjun Guo11,12, John S Condeelis13,14,15,16, Lalage M Wakefield17, Maja H Oktay18,19,20,21.   

Abstract

Cancer stem cells (CSCs) play an important role during metastasis, but the dynamic behavior and induction mechanisms of CSCs are not well understood. Here, we employ high-resolution intravital microscopy using a CSC biosensor to directly observe CSCs in live mice with mammary tumors. CSCs display the slow-migratory, invadopod-rich phenotype that is the hallmark of disseminating tumor cells. CSCs are enriched near macrophages, particularly near macrophage-containing intravasation sites called Tumor Microenvironment of Metastasis (TMEM) doorways. Substantial enrichment of CSCs occurs on association with TMEM doorways, contributing to the finding that CSCs represent >60% of circulating tumor cells. Mechanistically, stemness is induced in non-stem cancer cells upon their direct contact with macrophages via Notch-Jagged signaling. In breast cancers from patients, the density of TMEM doorways correlates with the proportion of cancer cells expressing stem cell markers, indicating that in human breast cancer TMEM doorways are not only cancer cell intravasation portals but also CSC programming sites.
© 2021. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34911937      PMCID: PMC8674234          DOI: 10.1038/s41467-021-27308-2

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  115 in total

1.  Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.

Authors:  Stephen B Keysar; Phuong N Le; Bettina Miller; Brian C Jackson; Justin R Eagles; Cera Nieto; Jihye Kim; Binwu Tang; Magdalena J Glogowska; J Jason Morton; Nuria Padilla-Just; Karina Gomez; Emily Warnock; Julie Reisinger; John J Arcaroli; Wells A Messersmith; Lalage M Wakefield; Dexiang Gao; Aik-Choon Tan; Hilary Serracino; Vasilis Vasiliou; Dennis R Roop; Xiao-Jing Wang; Antonio Jimeno
Journal:  J Natl Cancer Inst       Date:  2016-09-15       Impact factor: 13.506

2.  Nanoparticle Delivery of miR-708 Mimetic Impairs Breast Cancer Metastasis.

Authors:  Divya Ramchandani; Seung Koo Lee; Shira Yomtoubian; Myung Shin Han; Ching-Hsuan Tung; Vivek Mittal
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

3.  Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice.

Authors:  Etsuko Yamaguchi; Shigeru Chiba; Keiki Kumano; Atsushi Kunisato; Tokiharu Takahashi; Tsuyoshi Takahashi; Hisamaru Hirai
Journal:  Immunol Lett       Date:  2002-04-01       Impact factor: 3.685

Review 4.  Metastatic stem cells: sources, niches, and vital pathways.

Authors:  Thordur Oskarsson; Eduard Batlle; Joan Massagué
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

5.  TrackMate: An open and extensible platform for single-particle tracking.

Authors:  Jean-Yves Tinevez; Nick Perry; Johannes Schindelin; Genevieve M Hoopes; Gregory D Reynolds; Emmanuel Laplantine; Sebastian Y Bednarek; Spencer L Shorte; Kevin W Eliceiri
Journal:  Methods       Date:  2016-10-03       Impact factor: 3.608

6.  The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.

Authors:  Allison S Harney; George S Karagiannis; Jeanine Pignatelli; Bryan D Smith; Ece Kadioglu; Scott C Wise; Molly M Hood; Michael D Kaufman; Cynthia B Leary; Wei-Ping Lu; Gada Al-Ani; Xiaoming Chen; David Entenberg; Maja H Oktay; Yarong Wang; Lawrence Chun; Michele De Palma; Joan G Jones; Daniel L Flynn; John S Condeelis
Journal:  Mol Cancer Ther       Date:  2017-08-24       Impact factor: 6.261

Review 7.  CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.

Authors:  Philipp Grosse-Gehling; Christine A Fargeas; Claudia Dittfeld; Yvette Garbe; Malcolm R Alison; Denis Corbeil; Leoni A Kunz-Schughart
Journal:  J Pathol       Date:  2012-11-20       Impact factor: 7.996

Review 8.  Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer.

Authors:  Michael D Brooks; Monika L Burness; Max S Wicha
Journal:  Cell Stem Cell       Date:  2015-09-03       Impact factor: 24.633

9.  A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer.

Authors:  Joseph A Sparano; Robert Gray; Maja H Oktay; David Entenberg; Thomas Rohan; Xiaonan Xue; Michael Donovan; Michael Peterson; Anthony Shuber; Douglas A Hamilton; Timothy D'Alfonso; Lori J Goldstein; Frank Gertler; Nancy E Davidson; John Condeelis; Joan Jones
Journal:  NPJ Breast Cancer       Date:  2017-11-08

10.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more
  7 in total

1.  Medial prefrontal and occipito-temporal activity at encoding determines enhanced recognition of threatening faces after 1.5 years.

Authors:  Xiqin Liu; Xinqi Zhou; Yixu Zeng; Jialin Li; Weihua Zhao; Lei Xu; Xiaoxiao Zheng; Meina Fu; Shuxia Yao; Carlo V Cannistraci; Keith M Kendrick; Benjamin Becker
Journal:  Brain Struct Funct       Date:  2022-02-16       Impact factor: 3.270

Review 2.  Mechanisms and roles of podosomes and invadopodia.

Authors:  Stefan Linder; Pasquale Cervero; Robert Eddy; John Condeelis
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-14       Impact factor: 113.915

Review 3.  The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis.

Authors:  Xingxing Zhang; Wenxiu Bai; Lisha Hu; Hualan Ha; Yuelin Du; Wei Xiong; Hongbo Wang; Panfeng Shang
Journal:  Clin Transl Oncol       Date:  2022-09-07       Impact factor: 3.340

4.  Tumor Size Is an Independent Prognostic Factor for Stage I Ovarian Clear Cell Carcinoma: A Large Retrospective Cohort Study of 1,000 Patients.

Authors:  Liangcai Wu; Shuo Shi; Hong Sun; Haiyan Zhang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

Review 5.  Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Authors:  Michal A Rahat
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  An implantable ultrasound-powered device for the treatment of brain cancer using electromagnetic fields.

Authors:  Yilin Yang; Xiaoping Hu; Yuxin Liu; Bin Ouyang; Jiaxi Zhang; Huawei Jin; Zhenhua Yu; Ruiwei Liu; Zhe Li; Lelun Jiang; Xudong Lin; Bingzhe Xu
Journal:  Sci Adv       Date:  2022-07-22       Impact factor: 14.957

Review 7.  The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity.

Authors:  Md Nabiul Hasan; Okan Capuk; Shivani M Patel; Dandan Sun
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.